ATAI NASDAQ
Atai Beckley N.V
1W: -4.6%
1M: -19.2%
3M: +0.2%
YTD: +2.3%
1Y: +140.0%
3Y: +108.4%
$4.09
+0.13 (+3.28%)
Weekly Expected Move ±13.0%
$3
$3
$4
$5
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.5B
52W Range1.885-6.75
Volume3,414,825
Avg Volume5,834,652
Beta1.60
Dividend—
Analyst Ratings
Company Info
CEOSrinivas G. Rao
Employees54
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2021-06-18
Websiteataibeckley.com
Prof. J.H. Bavincklaan 7
Amstelveen 1183 AT
NL
Amstelveen 1183 AT
NL
31 20 793 2536
About Atai Beckley N.V
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
Latest News
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update
Trending stocks this week as markets weigh war risks and corporate results
AtaiBeckley: Anxiety Drug Cuts Social Phobia Symptoms By 38%
Why AtaiBeckley Stock Surged Today
AtaiBeckley Stock Skyrockets After Cantor Fitzgerald's Overweight Rating
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Feilding-Mellen Cosm | A-Award | 10,000 | $4.48 | 2025-11-25 |
| Feilding-Mellen Cosm | D-Return | 40,400 | $4.48 | 2025-11-25 |
| HERSHBERG ROBERT | A-Award | 456,011 | $1.35 | 2025-11-05 |
| HERSHBERG ROBERT | A-Award | 103,000 | $4.48 | 2025-11-05 |
| HERSHBERG ROBERT | A-Award | 97,716 | $1.35 | 2025-11-05 |